Skip Nav Destination
1-20 of 46
Acta Haematol (2022) 145 (6): 627–641.
Published Online: 05 August 2022
...Xin He; Yongfang Jiang; Xingbao Yu; Fei He; Haiyan Gao Introduction: The aim of the study was to construct a pyroptosis-related risk score (RS) model for the prognosis of acute myeloid leukemia (AML). Methods: The TARGET (training) and E-MTAB-1216 (validation) datasets were downloaded. Pyroptosis...
Thiti Asawapanumas, Nichthida Tangnantachai, Narittee Sukswai, Thammathorn Assanasen, Chantiya Chanswangphuwana, Panisinee Lawsut, Chantana Polprasert, Ponlapat Rojnuckarin, Udomsak Bunworasate, Kitsada Wudhikarn
Acta Haematol (2022) 145 (5): 542–552.
Published Online: 02 March 2022
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Programmed cell death Immune checkpoint Peripheral T-cell lymphoma Prognosis Immune checkpoint pathways play a critical role in immune system regulation, balancing...
Acta Haematol (2022) 145 (2): 132–143.
Published Online: 09 November 2021
...-treatment plasma EBV-DNA concentrations with treatment outcomes and prognosis in patients with PTCL. Methods: We retrospectively reviewed 128 patients diagnosed with PTCL with available data on pre-treatment plasma EBV-DNA, including 63 patients for whom post-treatment plasma EBV-DNA data were also...
Acta Haematol (2021) 144 (6): 603–612.
Published Online: 27 May 2021
...Jinkun Wu; Shupeima Ma; Lingling Sun; Zhiqiang Qin; Zheng Wang; Ning Wang; Mei Lin Background: Angiogenesis in non-Hodgkin lymphoma (NHL) has been investigated by a variety of studies. However, the correlation between angiogenesis and the occurrence or prognosis of NHL patients remains...
Laura Laine Herborg, Line Nederby, Rasmus Froberg Brøndum, Maria Hansen, Peter Hokland, Anne Stidsholt Roug
Acta Haematol (2021) 144 (3): 275–284.
Published Online: 03 December 2020
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Acute myeloid leukemia Flow cytometry Immunophenotype Mutations Prognosis In acute myeloid leukemia (AML), increasing knowledge...
Mihong Choi, Jeong-Ok Lee, Jongheon Jung, Ji Yun Lee, Eunyoung Lee, Hyewon Lee, Soo-Mee Bang, Hyeon Seok Eom, Jong Seok Lee
Acta Haematol (2019) 141 (3): 176–186.
Published Online: 27 February 2019
... patients with a worse prognosis within overlapping risk-groups by the prognostic index for PTCL. Conclusions: Our study showed that thrombocytopenia at diagnosis was an independent prognostic factor for survival in patients with PTCL. email@example.com 11 06 2018 8 11 2018 27 2...
Mihyang Ha, Ji-Young Kim, Myoung-Eun Han, Ga Hyun Kim, Si Young Park, Dae Cheon Jeong, Sae-Ock Oh, Yun Hak Kim
Acta Haematol (2018) 140 (2): 71–76.
Published Online: 10 September 2018
... cohort from The Cancer Genome Atlas (TCGA, n = 142). Results: Kaplan-Meier survival analysis revealed that TMEM18 overexpression was associated with a better AML prognosis with good discrimination ( p = 0.019). Interestingly, this ability to predict the prognosis was significant in male AML patients...
Xiaolu Song, Ye Peng, Xiaogang Wang, Yirui Chen, Lai Jin, Tianxin Yang, Meihua Qian, Wanmao Ni, Xiangmin Tong, Jianping Lan
Acta Haematol (2018) 139 (2): 115–127.
Published Online: 16 February 2018
... of death when compared to patients with a WHO type of AML-NOS. Conclusion: Our findings highlight the divergent outcomes of patients with AML and the importance of using the WHO classification system and demographic factors to gauge their prognosis. firstname.lastname@example.org 1 06 2017 10 12 2017...
Acta Haematol (2017) 137 (3): 132–140.
Published Online: 30 March 2017
... was found to be mainly unfit for the acute promyelocytic leukemia group. Forty-six patients (17.7%) had elevated fibrinogen levels (>4 g/L) and tended to have a poor prognosis, and thus we redetermined the cutoff value of fibrinogen (<1 g/L or >4 g/L was defined as abnormal). As a result, all...
Acta Haematol (2017) 137 (3): 117–122.
Published Online: 17 March 2017
...Yun Liang; Jie Gao; Dan Wu; Shu Li; Hang Chen; Luyin Ding; Jiefeng Tong; Yang Xu Multiple nonleukemic myeloid sarcoma (MS) is a rare form of MS that is developed in multiple anatomic sites other than bone marrow at diagnosis, without a preceding myeloid neoplasm. The prevalence, prognosis...
Acta Haematol (2017) 138 (3): 143–151.
Published Online: 01 March 2017
... 1.401-3.213) were independent inferior prognostic factors. Conclusions: IDH1 mutation is associated with a poor prognosis. Statistical analysis was performed with SPSS v17.0 (SPSS, Chicago, IL, USA). The differences between patients according to their IDH1 and IDH2 mutational status were tested...
Joji Nagasaki, Yasutaka Aoyama, Masayuki Hino, Kentaro Ido, Hiroyoshi Ichihara, Masahiro Manabe, Tadanobu Ohta, Atsuko Mugitani
Acta Haematol (2017) 137 (1): 32–39.
Published Online: 19 November 2016
... suggesting that acute myeloid leukemia patients with high expression levels of WT1 mRNA have a relatively poor long-term survival, there are few reports addressing the relationship between WT1 levels and prognosis in MDS. Methods: We retrospectively analyzed 42 elderly patients with MDS whose WT1 levels...
Acta Haematol (2016) 135 (3): 172–190.
Published Online: 01 March 2016
..., instructions or products referred to in the content or advertisements. 2016 Light-chain amyloidosis Prognosis Treatment Recognition Diagnosis Amyloidosis is a generic idiom for heterogeneous protein misfolding syndromes in which a culprit protein assembles in a β-sheet structure, resulting...
Aijun Liu, Guangzhong Yang, Chuanying Geng, Huijuan Wang, Lihong Li, Yanchen Li, Yin Wu, Ying Tian, Yun Leng, Guorong Wang, Wen Gao, Wenming Chen
Acta Haematol (2016) 135 (3): 140–145.
Published Online: 21 November 2015
...Aijun Liu; Guangzhong Yang; Chuanying Geng; Huijuan Wang; Lihong Li; Yanchen Li; Yin Wu; Ying Tian; Yun Leng; Guorong Wang; Wen Gao; Wenming Chen To analyze the effects of bortezomib on the prognosis of the newly diagnosed multiple myeloma patients with renal impairment, we assessed the outcomes...
Vehbi Ercolak, Semra Paydas, Emine Bagir, Melek Ergin, Gulsah Seydaoglu, Hikmet Celik, Basak Yavuz, Kahraman Tanriverdi, Meral Gunaldi, Cigdem U. Afsar, Berna B. Duman
Acta Haematol (2015) 134 (4): 199–207.
Published Online: 04 June 2015
... to in the content or advertisements. Disease-free survival Hodgkin’s lymphoma Immunohistochemistry Overall survival Preferentially expressed antigen of melanoma Prognosis Real-time polymerase chain reaction Hodgkin's lymphoma (HL) is a heterogeneous tumor that develops from germinal center...
Geunyoung Jung, Jin Roh, Hyangsin Lee, Minchan Gil, Doc Hyun Yoon, Cheolwon Suh, Seongsoo Jang, Chan-Jeoung Park, Jooryung Huh, Chan-Sik Park
Acta Haematol (2015) 134 (1): 17–24.
Published Online: 03 April 2015
... energy metabolism. Multiple myeloma (MM) is an indolent but eventually fatal neoplasm of plasma cells. Autophagy may play a critical role in the survival of MM cells and their response to chemotherapeutic agents. In this study, we correlated the expression of autophagy-related proteins with the prognosis...
Yunsuk Choi, Sung-Doo Kim, Young-Hoon Park, Jae Seok Lee, Dae-Young Kim, Jung-Hee Lee, Kyoo-Hyung Lee, Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Ah Rang Jung, Je-Hwan Lee
Acta Haematol (2015) 133 (2): 183–192.
Published Online: 11 October 2014
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Allogeneic hematopoietic cell transplantation Chemotherapy Myelodysplastic syndrome Prognosis Secondary acute myeloid leukemia Secondary acute myeloid leukemia (s...
José Carlos Jaime-Pérez, Alma Sirenia Brito-Ramirez, Monica Andrea Pinzon-Uresti, Homero Gutiérrez-Aguirre, Olga G. Cantú-Rodríguez, José Luis Herrera-Garza, David Gomez-Almaguer
Acta Haematol (2014) 132 (2): 144–151.
Published Online: 20 February 2014
... analyzed with respect to their influence on prognosis. Results: A total of 132 AML patients were included. Median age was 32 years. Complete remission (CR) was achieved by 55% of patients. CR was achieved by 65.1% of patients <60 years (n = 109), compared to 8.7% of those >60 years (n = 23; p...
Acta Haematol (2014) 131 (4): 231–238.
Published Online: 11 December 2013
..., p < 0.04, excluding high-risk vs. very high-risk comparison). We conclude that the IPSS-R has significant prognostic utility for MDS patients. Myelodysplastic syndrome Prognosis Revised International Prognostic Scoring System Survival Myelodysplastic syndrome (MDS...
Junshik Hong, Hyun-Hwa Yoon, Hee Kyung Ahn, Sun Jin Sym, Jinny Park, Pil-Whan Park, Jeong Yeal Ahn, Sanghui Park, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee
Acta Haematol (2013) 130 (4): 305–311.
Published Online: 31 August 2013
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Lactate dehydrogenase Non-Hodgkin lymphoma Diffuse large B cell lymphoma Prognosis Lactate dehydrogenase (LDH) is an enzyme found in almost all tissues of living...